↓ Skip to main content

Donepezil for mild cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, July 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
102 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Donepezil for mild cognitive impairment
Published in
Cochrane database of systematic reviews, July 2006
DOI 10.1002/14651858.cd006104
Pubmed ID
Authors

Jacqueline Birks, Leon Flicker

Abstract

Problems with memory which do not meet the diagnostic criteria for dementia, usually called mild cognitive impairment (MCI), can be the first sign of an impending dementia, particularly Alzheimer's disease (AD). There is no consensus on a definition or diagnostic criteria for MCI, and MCI remains a vague term and those so described are a heterogeneous population, consisting of people who may rapidly progress to dementia but also of people with stable cognitive deficits and some who may actually improve. Treatment in the very earliest stages of AD may delay progression to AD. Donepezil (Aricept, E2020), a cholinesterase inhibitor, has been shown to benefit all severities of AD including mild and it would be reasonable to investigate its efficacy for those with MCI.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Germany 1 <1%
France 1 <1%
United Kingdom 1 <1%
Ireland 1 <1%
Sweden 1 <1%
Ecuador 1 <1%
Unknown 107 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 19%
Student > Master 17 15%
Student > Ph. D. Student 16 14%
Student > Bachelor 12 11%
Student > Doctoral Student 8 7%
Other 39 34%
Readers by discipline Count As %
Medicine and Dentistry 39 34%
Psychology 14 12%
Agricultural and Biological Sciences 13 11%
Neuroscience 9 8%
Unspecified 8 7%
Other 31 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 December 2018.
All research outputs
#3,076,318
of 12,422,413 outputs
Outputs from Cochrane database of systematic reviews
#4,917
of 8,592 outputs
Outputs of similar age
#64,557
of 267,892 outputs
Outputs of similar age from Cochrane database of systematic reviews
#144
of 222 outputs
Altmetric has tracked 12,422,413 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,592 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.4. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,892 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 222 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.